Vitestro, developer of an autonomous blood drawing device, has completed a EUR 12 million Series A financing round. California-based Sonder Capital led the funding round alongside existing investors and new private investors with experience in the clinical laboratory and MedTech industry. The proceeds will be used to accelerate product development, prepare EU market authorization, and initiate production. Olym advised Sonder Capital on this investment.